This statistic depicts the percentage of the population who had eating disorders worldwide from 1990 to 2019. According to the data, the rate of eating disorders increased slightly from 1990 to 2019.

This statistic depicts the percentage of the U.S. population who had eating disorders from 1990 to 2019. According to the data, the rate of eating disorders increased slightly in the U.S. from .43 percent in 1990 to .46 percent in 2019.

This dataset explores the neurobehavioral factors related to eating disorders among university students in Bangladesh. The survey was distributed across various universities in Bangladesh via email and social media platforms. A total of 550 responses were collected between August and November 2024, with 296 students expressing a positive perception of eating disorders and 254 students expressing a negative perception. The dataset covers seven key factors: demographic, cognitive control, affective value representation, salience or taste processing, body image perception, reward processing or habit formation, and self-perception about eating disorders. This dataset offers valuable insights for researchers investigating the neurobiological underpinnings of eating disorders, supporting the development of brain-based models to better understand and address these conditions.

This statistic depicts the percentage of the population who had eating disorders worldwide from 1990 to 2019, by gender. According to the data, the rate of eating disorders among females increased slightly from .21 percent in 1990 to .24 percent in 2019.

From 2018 to 2019, around 2.03 million people in the U.S. had binge eating disorder, while around another 2.42 million had other specified feeding and eating disorders. This statistic illustrates the number of individuals in the United States with eating disorders from 2018 to 2019, by condition.

Introduction: Eating Disorders (EDs) are serious psychiatric disorders, impacting physical and psychosocial functioning, often with a chronic course and high mortality rates. The two continua model of mental health states that mental health is a complete state, that is, not merely the absence of mental illness, but also the presence of mental health. This model was studied among ED patients by examining the presence and correlates of well-being and psychopathology. In addition, the levels of well-being were compared to the Dutch general population.Method: A total of 468 female ED patients participated in this study during application and intake at a specialized ED treatment Center in the Netherlands. They filled out questionnaires about well-being (MHC-SF), general psychopathology (OQ-45), and ED psychopathology (EDE-Q). Categorical andmean well-being levels were calculated. Also, the relationships between these variables were examined with Pearson correlation and multiple hierarchical regression analysis.Results: ED patients showed lower levels of emotional, psychological, and social well-being on average compared to the general population. About 26% of the ED patients experienced low levels of well-being (languishing). However, also 13% experienced high levels of well-being (flourishing), varying between 9% in Anorexia Nervosa to 25% in Binge Eating Disorder. ED psychopathology and general well-being showed a moderate negative correlation. For patients with Bulimia Nervosa and Binge Eating Disorder however no such correlation was found. Lower general psychopathology, not having a history of hospitalization for the ED, and adaptive personal functioning were correlated with well-being among ED patients.Conclusion: This study shows initial support for the two continua model of mental health among ED patients. Psychopathology and well-being should be considered as related, but distinct dimensions of mental health in ED patients. Further research should focus on the possible reciprocal relationships between psychopathology and well-being during recovery. It is recommended to monitor well-being during treatment and to implement interventions for well-being to realize complete recovery for those patients with inadequate levels of well-being.

ABSTRACT Objective To quantify the prevalence and related factors to the risk of anorexia and bulimia nervosa in undergraduate students at a private university in Bogotá, Colombia. Methods A cross-sectional study, which evaluated the frequency of food consumption, physical activity (International Physical Activity Questionnaire, short form), the risk of anorexia and bulimia nervosa (Sick, Control, One, Fat, and Food questionnaire) and demographic variables. The statistical analysis used a multivariate logistic regression model, where the outcome was the yes/no risk of anorexia or bulimia nervosa. Results A total of 1,545 university students participated. The average age was 19.2 years (+/-2.5), 65.7% were women, and 63.9% came from Bogotá. The risk of anorexia and bulimia nervosa was 27.6%. In the logistic regression, the risk was associated with female sex (OR 1.6 CI95% 1.2 to 2.1), daily consumption of cereals (OR 0.7 CI95% 0.6 to 0.9), daily fat consumption (OR 1.5 CI95% 1.1 to 2.1), eat light products (OR 1.8 CI95% 1.1 to 2.9), consume protein supplements (OR 0.4 CI95% 0.2 to 0.8), being in disagreement with physical activity for fun (OR 1.8 CI95% 1.1 to 3.1), and physical activity by appearance (OR 2.2 CI95% 1.6 to 2.9). Conclusions The prevalence of risk to anorexia and bulimia nervosa in the study sample is high. The associated factors were the consumption of cereals, fat, light products, and protein supplements. Physical activity by appearance and disagreement to do exercise by fun were associated with the risk of anorexia and bulimia nervosa. So it is recommended that universities implement awareness and education interventions to address this problem.

The global market for bulimia nervosa treatment is experiencing significant growth, driven by increasing awareness of the disorder, improved diagnostic tools, and the development of more effective therapies. While precise market sizing data is unavailable, considering the prevalence of eating disorders and the rising healthcare expenditure globally, a reasonable estimate for the 2025 market size could be around $2 billion USD. This figure reflects the combined value of pharmacological interventions (antidepressants, anti-anxiety medications), psychotherapeutic treatments (cognitive behavioral therapy, dialectical behavior therapy), and other supportive services. A conservative Compound Annual Growth Rate (CAGR) of 5% over the forecast period (2025-2033) is projected, considering factors like ongoing research into novel treatments and increasing access to mental healthcare. This translates to a projected market value exceeding $3 billion by 2033. Major pharmaceutical companies like Eli Lilly, AstraZeneca, Pfizer, and others play crucial roles in developing and marketing pharmacological interventions, contributing significantly to the market value. However, market growth faces restraints, including the stigma associated with eating disorders leading to underdiagnosis and treatment gaps, especially in low- and middle-income countries. Furthermore, the effectiveness of current treatments varies among individuals, highlighting the need for personalized approaches and further research into alternative therapies. The segmentation of the market is primarily based on treatment modality (pharmacological vs. psychotherapy), patient demographics (age, gender), and geographic location. North America and Europe currently dominate the market due to higher awareness, better access to healthcare, and a larger pool of patients receiving treatment. However, emerging markets in Asia and Latin America present significant growth opportunities as awareness campaigns and improved healthcare infrastructure increase access to treatment. Future market trends indicate a continued focus on developing personalized treatment plans, incorporating digital health solutions for remote monitoring and support, and promoting early intervention programs to prevent the development of chronic bulimia nervosa. The ongoing research and development efforts by pharmaceutical companies and academic institutions, combined with increased healthcare investment, will be key factors driving sustained market growth in the long term.

Introduction

New York, NY – January 15, 2025 – Global Virtual Eating Disorder Treatment Market size is expected to be worth around USD 2,072.0 Million by 2033 from USD 836.1 Million in 2023, growing at a CAGR of 9.5% during the forecast period from 2024 to 2033. In 2023, North America led the market, achieving over 42.7% share with a revenue of US$ 357 Million.

The Virtual Eating Disorder Treatment Market is experiencing significant growth, driven by advancements in telehealth technology and increasing awareness about mental health. This market encompasses digital platforms, teletherapy services, and mobile applications designed to provide tailored support for individuals struggling with eating disorders such as anorexia, bulimia, and binge eating.

Key drivers of market expansion include the rising prevalence of eating disorders globally, with approximately 9% of the world's population affected annually. The demand for accessible and convenient treatment options has surged, particularly post-COVID-19, as traditional in-person therapy faced challenges. Virtual treatment solutions offer benefits like real-time monitoring, personalized care, and flexibility, enabling patients to access support from their homes.

Innovations such as AI-driven therapy bots, mobile apps for self-monitoring, and integration with wearable devices are further transforming the landscape. Partnerships between healthcare providers and technology firms are also fueling advancements. North America holds a significant market share due to robust telehealth infrastructure and increased investment in digital health solutions. However, regions like Europe and Asia-Pacific are emerging rapidly, driven by growing mental health awareness campaigns.

Abstract Background Understanding of the epidemiology and health burden of eating disorders has progressed significantly in the last 2 decades. It was considered one of seven key areas to inform the Australian Government commissioned National Eating Disorder Research and Translation Strategy 2021–2031, as emerging research had highlighted a rise in eating disorder prevalence and worsening burden-of-illness. The aim of this review was to better understand the global epidemiology and impact of eating disorders to inform policy decision-making. Methods Using a systematic Rapid Review methodology, ScienceDirect, PubMed and Medline (Ovid) were searched for peer-reviewed studies published between 2009 and 2021. Clear inclusion criteria were developed in consultation with experts in the field. Purposive sampling of literature was conducted, which predominately focused on higher-level evidence (meta-analyses, systematic reviews, and large epidemiological studies), synthesised, and narratively analysed. Results 135 studies were deemed eligible for inclusion in this review (N = 1324). Prevalence estimates varied. Global Lifetime prevalence of any eating disorder ranged from 0.74 to 2.2% in males, and 2.58–8.4% in females. Australian 3-month point-prevalence of broadly defined disorders was around 16% in females. Eating disorders appeared more prevalent in young people and adolescents, particularly females (in Australia: eating disorders ~ 22.2%; disordered eating ~ 25.7%). Limited evidence was found on sex, sexuality and gender diverse (LGBTQI +) individuals, particularly males, who had a six-fold increase in prevalence compared to the general male population, with increased illness impact. Similarly, limited evidence on First Australian’s (Aboriginal and Torres Strait Islander) suggests prevalence rates similar to non-Indigenous Australians. No prevalence studies were identified specifically assessing culturally and linguistically diverse populations. Global disease burden of any eating disorder was 43.4 age-standardised disability-adjusted-life-years per 100,000; increasing by 9.4% between 2007 and 2017. Australian’s total economic cost was estimated at $84 billion from years-of-life lost due to disability and death, and annual lost earnings ~ $1.646 billion.” Conclusions There is no doubt that eating disorder prevalence and impact are on the rise, particularly in at-risk and understudied populations. Much of the evidence came from female-only samples, and Western, high-income countries which more readily have access to specialised services. Future research should examine more representative samples. There is an urgent need for more refined epidemiological methods to better understand these complex illnesses over time, to guide health policy and development-of-care.

According to a survey conducted in England in 2023, cases of any eating disorder were found to be more prevalent among girls aged between 17 and 19 years, with 20.8 percent of respondents reporting suffering from an eating disorder. This statistic displays the percentage of children and young people with an eating disorder in England in 2023, by age and gender.

Introduction. This database includes the raw data linked with the paper “Life events in the etiopathogenesis and maintenance of restrictive eating disorders in adolescence. In this paper, we reported sociodemographic features, family history of any DSM-5 psychiatric disorder, personal history of any DSM-5 psychiatric disorder, life events, Restrictive Eating Disorder (RED) severity, and psychopathological assessment. We aimed to explore the presence of significant life events in the study population diagnosed with RED in the year prior to enrolment; to explore the relationship between the presence of life events and the severity of RED and their psychological maladjustment; to explore the relationship between the presence of traumatic and protective life events and the severity of RED and their psychological maladjustment

Methods. We enrolled 33 female adolescent patients (12-18), with a diagnosis of RED and confirmed by K-SADS, who compiled Eating Disorder Inventory (EDI-3) questionnaire and Coddington Life Events Scales (CLES-A).

Results (in brief). The 87.88% of the patients reported a life event in the past year. A significant association emerged between elevated clinical General Psychological Maladjustment Composite (GPMC) and the presence of traumatic event: it shows that patients who had experienced at least one traumatic life event in the year prior to enrolment presented higher clinically elevated general psychological maladjustment compared to patients who had not.

ANR: Anorexia Nervosa Restricting type; ANP: Anorexia Nervosa Binge Eating/Purging type; EDNOS: Eating Disorders Not Otherwise Specified. Significance differences between Warm and Cold groups, *p

Prevalence of Eating Disorder Features.

Anorexia Nervosa Treatment Market Outlook

The global anorexia nervosa treatment market is poised for significant growth, with a market size projected to expand from USD 1.2 billion in 2023 to USD 2.1 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.4%. Several growth factors are driving this expansion, including increased awareness of mental health issues, advancements in therapy and pharmacological treatments, and the rising incidence of eating disorders worldwide. With an increasing number of individuals seeking treatment, the demand for comprehensive and effective solutions for anorexia nervosa is on the rise.

One of the primary growth factors in the anorexia nervosa treatment market is the increasing awareness and destigmatization of mental health disorders. Over the past decade, there has been a paradigm shift in how society perceives mental health, leading to a surge in individuals seeking support and treatment. Campaigns and educational programs highlighting the seriousness of eating disorders have played a crucial role in encouraging more people to seek professional help. This heightened awareness has not only increased the number of diagnosed cases but also necessitated the development of specialized treatment options, thus bolstering market growth.

Technological advancements in therapeutic modalities are also a key driver of market expansion. Innovations in cognitive-behavioral therapy (CBT), as well as the integration of digital health platforms, have broadened treatment possibilities. Virtual therapy sessions, mobile health applications, and online support groups have made it easier for patients to access care, irrespective of their geographical location. These technological innovations have not only improved patient adherence to treatment plans but also expanded the reach of healthcare professionals, making it possible to cater to a larger patient base, thereby positively impacting market growth.

The rising prevalence of anorexia nervosa is another significant growth factor. As lifestyles change and societal pressures increase, the incidence of eating disorders, particularly among adolescents and young adults, is on the rise. This growing patient demographic is driving the demand for effective treatment solutions. Moreover, healthcare systems are increasingly recognizing the long-term health implications of untreated anorexia nervosa, leading to more robust healthcare pathways and funding for research and development in this area. These efforts aim to provide earlier intervention and more personalized treatment plans, further propelling market growth.

Regionally, the market outlook varies significantly, with North America leading the charge due to advanced healthcare infrastructure and a high prevalence of eating disorders. Europe follows closely, benefiting from strong healthcare policies and significant investments in mental health research. The Asia Pacific region is expected to witness the highest growth rate, driven by an increasing awareness of mental health issues, urbanization, and improved access to healthcare services. Meanwhile, the Middle East & Africa and Latin America are gradually catching up as they enhance their healthcare infrastructure and promote mental health awareness. These regional dynamics play a crucial role in shaping the global anorexia nervosa treatment market.

Treatment Type Analysis

The anorexia nervosa treatment market is segmented by treatment types, which include therapeutic, pharmacological, and nutritional interventions. Among these, therapeutic treatments, particularly psychotherapy, hold a significant share owing to their efficacy in addressing the psychological root causes of anorexia nervosa. Cognitive-behavioral therapy (CBT) remains a cornerstone in therapeutic interventions, providing patients with coping mechanisms and strategies to alter distorted thought patterns related to body image and food. Moreover, advancements in psychotherapeutic techniques, such as family-based therapy and dialectical behavior therapy, continue to evolve, broadening the scope of treatment options available to patients.

Pharmacological treatments, though less dominant than therapeutic approaches, are gaining traction as adjunctive therapies. Medications such as antidepressants and antipsychotics are often prescribed to manage co-occurring psychiatric conditions that accompany anorexia nervosa, such as depression and anxiety. Recent research into pharmacotherapy is focused on developing drugs that target the neurobiological underpinnings of eating disorders, offering hope for more targeted and effective trea

Pica Eating Disorder Treatment Market Outlook

The global market size for Pica Eating Disorder Treatment was valued at approximately USD 1.8 billion in 2023 and is projected to reach around USD 3.5 billion by 2032, growing at a CAGR of approximately 7.5% during the forecast period. The increasing awareness about mental health issues and the rising prevalence of eating disorders are key factors driving the market's growth.

One significant growth factor in the Pica Eating Disorder Treatment market is the increasing recognition and diagnosis of eating disorders. In recent years, there has been a substantial rise in awareness campaigns and educational programs aimed at identifying and understanding eating disorders, including pica. This has led to earlier diagnoses and an increased demand for effective treatments. The destigmatization of mental health issues and the growing acceptance of seeking medical help have also contributed to this upsurge. Additionally, the integration of mental health services into primary healthcare settings has facilitated easier access to diagnosis and treatment for a larger portion of the population.

Another driving force is the advancements in therapeutic approaches and medications used in treating pica eating disorder. Behavioral therapy and nutritional therapy have shown significant efficacy in managing the symptoms and underlying causes of pica. Innovations in pharmacological interventions have also enhanced the treatment outcomes. As research in this field progresses, new medications and combined therapy approaches are being developed, which offers substantial promise in improving patient outcomes. The ongoing research and development activities in this domain are expected to further fuel the market's growth during the forecast period.

The rising healthcare expenditure and the growing number of specialized treatment centers are also propelling the market. Governments and private organizations are increasingly investing in healthcare infrastructure, which includes dedicated centers for mental health and eating disorders. These investments are making specialized care more accessible to patients, thus driving the demand for pica eating disorder treatments. Moreover, collaborations between healthcare providers and insurance companies have improved the affordability of these treatments, encouraging more individuals to seek professional help.

In terms of regional outlook, North America holds the largest market share due to its advanced healthcare infrastructure, high awareness levels, and significant healthcare spending. Europe follows closely, benefiting from robust healthcare systems and increasing public awareness campaigns. The Asia Pacific region is expected to witness the highest growth rate, driven by increasing urbanization, changing lifestyles, and growing awareness about mental health issues. Emerging markets in Latin America and the Middle East & Africa are also showing a gradual increase in market share as healthcare access and awareness improve in these regions.

The market for Binge Eating Disorder Drug is also witnessing significant developments. As awareness about binge eating disorder increases, there is a growing demand for effective pharmacological treatments. This disorder, which is characterized by recurrent episodes of eating large quantities of food, often leads to serious health complications if left untreated. Recent advancements in drug therapies are providing new hope for patients. These medications aim to regulate appetite and reduce the frequency of binge eating episodes, thereby improving overall health outcomes. The ongoing research and development in this field are expected to bring forth more targeted and effective drug options, further expanding the treatment landscape for binge eating disorder.

Treatment Type Analysis

The Pica Eating Disorder Treatment market can be segmented by treatment type into Behavioral Therapy, Nutritional Therapy, and Medication. Behavioral Therapy is one of the most commonly used treatments for pica. It involves interventions such as cognitive-behavioral therapy (CBT) and habit-reversal training, which aim to address the psychological aspects of the disorder. Behavioral therapy has shown significant promise in reducing the compulsion to eat non-food items by helping patients develop healthier coping mechanisms. The adoption of these therapies is expected to increase as more clinical evidence supports their effectiveness, and as more therapists b

Gender Mental Disorder Prevalence

Investigating Differences Across Cultures and Continents

By Reisha Hermana [source]

About this dataset

This dataset provides the gender-based prevalence of mental health disorders around the world in 2019. It includes data about eating disorders, bipolar disorder, and population estimates for each country or region included in the dataset. The data reveals mental health disparities across countries and continents by showing different levels of prevalence amongst males versus females. This valuable resource allows us to understand more deeply our current global mental health situation, while also providing an insight into potential areas for improvement and progress in terms of both diagnosis and access to care

More Datasets

For more datasets, click here.

Featured Notebooks

• 🚨 Your notebook can be here! 🚨!

How to use the dataset

This dataset provides the prevalence of eating disorders and bipolar disorder among males and females in different countries from 2019. This dataset can be useful for researchers looking to compare the prevalence of these mental disorders between genders, or across regions.

Research Ideas

• To understand geographic patterns in mental health disorders. This data can be used to enhance our understanding of which parts of the world are more likely to experience different types of mental health disorders and how prevalence can vary from continent to continent.
• To compare prevalence between males and females in terms of mental health disorders and highlight potential differences among different areas/countries/continents.
• To explore trends in mental health over time and assess which populations have seen the most improvement or decline within a certain period (e.g., check if there is any correlation between trends in bipolar disorder prevalence for males versus those for females across countries)

Acknowledgements

If you use this dataset in your research, please credit the original authors. Data Source

License

License: Dataset copyright by authors - You are free to: - Share - copy and redistribute the material in any medium or format for any purpose, even commercially. - Adapt - remix, transform, and build upon the material for any purpose, even commercially. - You must: - Give appropriate credit - Provide a link to the license, and indicate if changes were made. - ShareAlike - You must distribute your contributions under the same license as the original. - Keep intact - all notices that refer to this license, including copyright notices.

Columns

File: prevalence-of-eating-disorders-in-males-vs-females.csv | Column name | Description | |:----------------------------------------|:-----------------------------------------------------------------------------------------------------| | Entity | The name of the country or region. (String) | | Code | The ISO 3166-1 alpha-3 code for the country or region. (String) | | Year | The year the data was collected. (Integer) | | Prevalence - Eating disorders - Sex | The prevalence of eating disorders among females, age-standardized to the global population. (Float) | | **Prevalence ** | Female - Age | | Population (historical estimates) | The estimated population of the country or region. (Integer) | | Continent | The continent the country or region is located in. (String) |

File: prevalence-of-bipolar-disorder-in-males-vs-females.csv | Column name | Description | |:----------------------------------------|:---------------------------------------------------------------------------------------------------------------| | Entity | The name of the country or region. (String) | | Code ...

The size and share of this market is categorized based on Therapeutic Approaches (Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), Interpersonal Therapy (IPT), Medication Management, Support Groups) and Treatment Type (Pharmacological Treatment, Psychotherapy, Nutritional Counseling, Combination Therapy, Self-Help Programs) and Patient Demographics (Adults, Adolescents, Children, Elderly, Gender-specific Treatments) and geographical regions (North America, Europe, Asia-Pacific, South America, Middle-East and Africa).

According to a survey conducted in England in 2023, anorexia cases were found to be more prevalent among girls aged between 17 and 19 years, with over six percent of respondents reporting they suffer from this eating disorder. This statistic displays the percentage of children and young people with anorexia nervosa in England in 2023, by age and gender.

This statistic displays the number of adults with an eating disorder in the United States in the period 2008-2012, by gender. During this time, some 9,000 males in the country had bulimia nervosa. Many cases of eating disorders are likely to go unreported.